2021
DOI: 10.1007/s11033-021-06262-8
|View full text |Cite
|
Sign up to set email alerts
|

Proteomic profiling of clinical and environmental strains of Pseudomonas aeruginosa

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
3
1
1
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 48 publications
0
3
0
Order By: Relevance
“…In Xu et al [ 40 ], that investigated the inhibitory effects of P. aeruginosa strains against gram-negative bacteria, similar variations in inhibition were observed. The strains exhibited different degrees of inhibition against the tested bacteria, indicating strain-specific differences in antimicrobial activity [ 40 , 41 ]. However, the specific strains and bacterial targets used in the study differed from those used in the current study, emphasizing the importance of considering strain and pathogen specificity when comparing results.…”
Section: Discussionmentioning
confidence: 99%
“…In Xu et al [ 40 ], that investigated the inhibitory effects of P. aeruginosa strains against gram-negative bacteria, similar variations in inhibition were observed. The strains exhibited different degrees of inhibition against the tested bacteria, indicating strain-specific differences in antimicrobial activity [ 40 , 41 ]. However, the specific strains and bacterial targets used in the study differed from those used in the current study, emphasizing the importance of considering strain and pathogen specificity when comparing results.…”
Section: Discussionmentioning
confidence: 99%
“…Common characteristics for P. aeruginosa to represent the MDR behavior in clinical strains are the presence of drug resistance genes or its mutant variety in bacterial plasmid or in its genome, high expression of a β-lactamase group of enzymes, and up-regulation of drug efflux pump have been documented [ 36 39 ]. Interestingly, a recent effort using proteomic profiling has characterized antibiotics sensitive and MDR clinical strains of P. aeruginosa that provided non-genetic changes associated with antibiotic susceptibility responses [ 40 ].…”
Section: Discussionmentioning
confidence: 99%
“…Common characteristics for P. aeruginosa to represent the MDR behavior in clinical strains are presence of drug resistance genes or its mutant variety in bacterial plasmid or in its genome, high expression of β-lactamase group of enzymes, and up regulation of drug efflux pump have been documented [36][37][38][39]. Interestingly, a recent effort using proteomic profiling has characterized antibiotics sensitive and MDR clinical strains of P. aeruginosa that provided non-genetic changes associated with antibiotic susceptibility responses [40].…”
Section: Discussionmentioning
confidence: 99%